WASHINGTON (Reuters) – U.S. officials met again with RSV vaccine manufacturers this week amid ongoing efforts to boost access to the shots, the White House said in a statement on Thursday after senior Biden administration officials met with the companies last week.
The officials on Tuesday met with representatives of Sanofi SA, AstraZeneca and Thermo Fisher “and urged them to work expeditiously to meet demand for immunizations this winter season through the commercial market,” the White House said in a statement.
(Reporting by Susan Heavey and Katharine Jackson; editing by Rami Ayyub)
